A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

BACKGROUND: Cardiac pathological hypertrophy is associated with a significantly increased risk of coronary heart disease and has been observed in diabetic patients treated with rosiglitazone whereas most published studies do not suggest a similar increase in risk of cardiovascular events in pioglita...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Verschuren, Lars, Wielinga, Peter Y, Kelder, Thomas, Radonjic, Marijana, Salic, Kanita, Kleemann, Robert, van Ommen, Ben, Kooistra, Teake
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4072889/
https://ncbi.nlm.nih.gov/pubmed/24938300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-7-35
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados